4.6 Letter

MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article

Mcl-1 Ubiquitination and Destruction

Hiroyuki Inuzuka et al.

Oncotarget (2015)

Article Oncology

Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias

Bella S. Guerrouahen et al.

CLINICAL CANCER RESEARCH (2010)

Article Hematology

Tumor necrosis factor-related apoptosis-inducing ligand and the regulation of hematopoiesis

Paola Secchiero et al.

CURRENT OPINION IN HEMATOLOGY (2008)

Review Oncology

The role of FLT3 in haematopoietic malignancies

DL Stirewalt et al.

NATURE REVIEWS CANCER (2003)